Trump announces trade deal with EU following months of negotiations
Robert Thomas Freeman, the Chief Financial Officer of Alignment Healthcare, Inc. (NASDAQ:ALHC), a $3.3 billion market cap healthcare company whose stock has surged 258% over the past year, recently sold shares of the company’s common stock totaling $420,838. The transactions, disclosed in a recent SEC filing, took place on March 18 and 19, 2025, and involved the sale of 25,247 shares. The shares were sold at prices ranging from $16.088 to $16.9588 per share, with the stock currently trading near its 52-week high at $17.19. According to InvestingPro, the company operates with moderate debt levels but remains unprofitable, with a loss per share of $0.67 over the last twelve months.
The sales were executed to cover tax withholding obligations related to the vesting of restricted stock units and an immediately vested common stock grant. Following these transactions, Freeman holds 1,471,163 shares in direct ownership and 92,929 shares indirectly through FCO Holdings LLC. For deeper insights into ALHC’s financial health and detailed analysis, subscribers can access the comprehensive Pro Research Report on InvestingPro.
In other recent news, Alignment Healthcare reported its fourth-quarter 2024 earnings, surpassing analysts’ expectations with an EPS of -0.16 compared to the forecast of -0.18. The company’s revenue also exceeded projections, reaching $701.2 million against the expected $674.97 million, marking a significant achievement for the company. Piper Sandler demonstrated confidence in Alignment Healthcare’s future performance by raising the price target to $21.00 from $14.00, maintaining an Overweight rating. Similarly, Raymond (NSE:RYMD) James increased the price target to $19.00 from $14.00, reiterating a Strong Buy rating, following the company’s robust fourth-quarter performance. Alignment Healthcare’s membership grew by 59% in 2024, with significant expansion outside California, and the company achieved its first year of adjusted EBITDA profitability. Looking ahead, the company provided guidance for 2025, forecasting revenue between $3.72 billion and $3.78 billion, with adjusted gross profit expected to range from $415 million to $445 million. The company anticipates membership to grow to between 227,000 and 233,000, emphasizing its expansion strategy. Analysts from Piper Sandler and Raymond James highlighted the company’s potential for sustained growth and profitability, citing its strategic approach and robust performance.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.